Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14141223 | 0.73 | — | — | |
| SCHEMBL15656739 | 0.69 | TSHR (0.35) | TSHRTDP1 | |
| SCHEMBL19924581 | 0.67 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL14266207 | 0.67 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL9677474 | 0.67 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL135476 | 0.67 | — | — | |
| SCHEMBL21925362 | 0.67 | TSHR (0.40) | TSHRTDP1 | |
| SCHEMBL19492027 | 0.65 | TSHR (0.32) | TSHRTDP1 | |
| SCHEMBL3546063 | 0.65 | — | — | |
| SCHEMBL23978043 | 0.64 | TSHR (0.38) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7709680-B2 | Preparation of polyisocyanates containing uretdione groups using phosphine catalysts | BAYER MATERIALSCIENCE AG (DE) | 2010-05-04 | — | — | US | disclosed |
| EP-1982979-B1 | Manufacture of polyisocyanates containing uretdione groups | BAYER MATERIALSCIENCE AG (DE) | 2010-01-27 | — | — | EP | disclosed |
| US-20080262262-A1 | Preparation of polyisocyanates containing uretdione groups using phosphine catalysts | BAYER MATERIALSCIENCE AG | 2008-10-23 | — | — | US | disclosed |
| EP-1982979-A1 | Manufacture of polyisocyanates containing uretdione groups | Bayer MaterialScience AG (DE) | 2008-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262262-A1 | Preparation of polyisocyanates containing uretdione groups using phosphine catalysts | PPIP5K2, IPMK, INPP5B | TSHR 4316/4885TDP1 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.